206 results on '"Spangaro M"'
Search Results
2. Psychopharmacology
3. Targeting anxiety to improve quality of life in patients with schizophrenia
4. Cognitive remediation and functional improvement in schizophrenia: Is it a matter of size?
5. Associated neurophysiological and neuropsychological patterns toward personalized rehabilitation in schizophrenia
6. The cascade effect of autistic symptoms on pragmatics in schizophrenia: the role of executive functions and theory of mind
7. Investigating the relationship between the kynurenine pathway and treatment resistance in schizophrenia
8. Combined neurocognitive and metacognitive rehabilitation in schizophrenia: Effects on bias against disconfirmatory evidence
9. Signature of psychotic features on white matter in bipolar disorder and schizophrenia
10. Exploring the interplay between kynurenine pathway, cognition, metabolic syndrome and treatment resistance in schizophrenia
11. Cognitive impairment in schizophrenia – disentangling the role of metabolic syndrome and inflammation
12. P.0771 Targeting quality of life in schizophrenia: the fil rouge between metabolic syndrome and anxiety
13. P.0488 Treatment-resistance as a predictor of cognitive remediation outcome in schizophrenia
14. P.0466 Combined effect of treatment-resistance and autistic traits on sociocognitive abilities in schizophrenia
15. P.0782 Clozapine to N-Desmethylclozapine ratio in treatment resistant schizophrenia: clinical implications from psychopathology to cognition
16. Combined social cognitive and neurocognitive rehabilitation strategies in schizophrenia: neuropsychological and psychopathological influences on Theory of Mind improvement
17. Factors affecting cognitive remediation outcome in schizophrenia: The role of treatment resistance
18. P.205 White matter integrity, clinical symptoms and quality of life in schizophrenia: a DTI study
19. Enhancing cognitive remediation therapy with transcranial direct current stimulation: preliminary findings in schizophrenia
20. Epigenetics in schizophrenia and association with antipsychotic response to clozapine: preliminary findings
21. Effects of the interaction between adducins and EAAT2 polymorphisms on cognition in schizophrenia: preliminary findings
22. Results of Surgical Therapy of Achalasia with Three Different Techniques
23. Twenty-Four-Hour Home Esophageal pH Monitoring (EpH) in the Diagnosis of Gastroesophageal Reflux: Is It Worthwhile?
24. Cognitive Remediation and Functional Improvement in Schizophrenia: is it a Matter of Size?
25. P1.i.029 Effect of catechol-O-methyltransferase polymorphism on subcortical volumes in schizophrenia
26. P.3.b.021 Interleukin-1β, cognition and metabolic syndrome in schizophrenia
27. P.3.b.034 Interaction of EAAT2 genotype and clozapine on cognitive remediation outcome
28. P.3.b.029 Antipsychotics, metabolic syndrome and schizophrenia: investigating the role of SREBF polymorphisms
29. P.3.a.014 Exploring the effect of genetic variability of adducins on cognition in schizophrenia
30. P.3.a.009 Effects of the interaction between adducins and EAAT2 polymorphisms on cognition in schizophrenia: preliminary findings
31. P.1.g.010 Exploring effects of EAATs polymorphisms on cognitive functions in schizophrenia
32. P.3.e.016 Self-awareness of cognitive functioning in schizophrenia: patients and their relatives
33. P.3.a.016 Effects of catechol-O-methyltransferase Val108/158Met and Saitohin q7r polymorphisms on cognitive functions in schizophrenia
34. P.3.d.082 Enhancing cognitive remediation therapy with transcranial direct current stimulation: preliminary findings in schizophrenia
35. 110. Experience in Treatment of 103 Liver Injuries
36. Exploring effects of EAATs polymorphisms on cognitive functions in schizophrenia
37. Is longer treatment better? A comparison study of 3 vs 6 months cognitive remediation in schizophrenia
38. Effects of catechol-O-methyltransferase Val108/158Met and Saitohin q7r polymorphisms on cognitive functions in schizophrenia
39. Effect of catechol-O-methyltransferase polymorphism on subcortical volumes in schizophrenia
40. Interaction of EAAT2 genotype and clozapine on cognitive remediation outcome
41. Antipsychotics, metabolic syndrome and schizophrenia: investigating the role of SREBF polymorphisms
42. Interleukin-1 beta, cognition and metabolic syndrome in schizophrenia
43. Exploring the effect of genetic variability of adducins on cognition in schizophrenia
44. Biliary cystadenocarcinoma. A case report,Il cistoadenocarcinoma biliare. Descrizione di un caso
45. Rupture of the azygos vein in blunt chest trauma
46. Pathophysiology and natural history of acquired short esophagus
47. KLATSKIN'S TUMORS: IS AN ONCOLOGICALLY RADICAL PROCEDURE POSSIBLE?
48. SURGICAL MANAGEMENT OF CHOLEDOCHAL CYSTS.
49. Stability and generalization of combined theory of mind and cognitive remediation interventions in schizophrenia: Follow-up results
50. Functional benefits of co-occurring autistic symptoms in schizophrenia is delimited by symptom severity
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.